chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pain in arm, tingle in fingers. Pain in leg tingle in toes right after shot.  Forty minutes after shot, mouth and neck became swollen, then lips started swelling and were numb.  On the way back to facility, tongue  and throat started swelling.  Wheezing started after that.
I "tasted" the vaccine in my mouth immediately after being given.  This lasted for 48 hours.
I went to clinic for a routine scheduled vaccination (not a COVID vaccine). The pharmacist assumed I was there for a COVID shot and administered one without any screening/checks/questions. I was already fully vaccinated against COVID - I received both doses of the Pfizer vaccine (on 3/24 and 4/14).  The pharmacist administered an erroneous Moderna shot on 5/17.
Information has been received from a consumer, via a company representative, concerning the consumer's 19 year old daughter, with diabetes, who was vaccinated with a dose, 0.5ml, of Gardasil (date unspecified). Concomitant therapy included hepatitis A virus vaccine (unspecified). The mother reported that her daughter experienced "tingling in her fingertips after receiving Gardasil. The patient sought unspecified medical attention. Additional information is not expected.
Initial report received from a healthcare professional on 01 November 2013. A 63-year-old female patient had received first dose of FLUZONE intradermal (batch number and route of administration was not reported) on 30 October 2013. The patient had a history of sulfa allergy and concomitant medications were not reported. On 30 October 2013, same day after vaccination, the patient injection site was palm sized, red and raised, felt like a knot under site and was extremely itchy. The patient's laboratory tests and corrective treatments were not reported. At the time of this report, the patient was not recovered. Documents held by sender was none.
Lt. arm some mild erythema and induration over deltoid and upper arm.  lateral surface no crepitus no unsual discoloration.  Diameter Rt. Biceps 16cm left 18.5 no axillary lymphadenopathy on left. Assessment.  Immuunization reaction left arm with pruritus.
Infant broke out in hives after receiving vaccines DTAP, IPV, HIB, Prevnar. No respiratory distress noted. Child alert and smiling. Child had no reaction after same vaccine were given at age 2 months. Infant was taken to Dr's office where oral Benadryl was administered.
Information has been received from a consumer concerning a 9 yr old male who was vaccinated with a dose of varicella virus vaccine live. On 23Apr05 the pt experienced 4 chickenpox like lesions. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Constant consistent noticeable pain in upper left arm where all three shots were given.  Some joint pain/finger joint pain in left arm and hand, lymph node pain below ears; under arms.
erythematous papular rash starting in a circular pattern around MMR inject site; + urticaria cont to spread to other leg about 2 hrs p/inject;
Pt presented pale, diaphoretic, with cold clammy skin @ 12:18 PM, approx. 3 minutes after receiving her first Pfizer dose. Pt positioned changed to supine with her feet elevated. Vitals @ 12:18 are: BP: 90/67 P: 85 RR: 17 O2: 100% T: 97.3. At 12:21 Pt reported feeling better and no longer presented with any previously mentioned symptoms. Pt vitals @ 12:21 are: BP: 129/67 P: 97 RR: 20 O2: 100% T: 97.1. Pt remained in supine positioned and RN continued to monitor. At 12:36 pt position changed to sitting up, water was given upon pt request. Last set of vitals before discharge at 12:45 are BP: 113/67 P: 74 RR: 20 O2: 98% T: 98. Pt was discharged with her mom.
Five months after I got the vaccine, I developed a very sore throat. My family members had had a similar illness and tested negative for COVID-19. I felt more unwell the next day and I was very fatigued. I went to the Urgent care to get a Lung X Ray because I have a history of Pneumonia. My cough was very severe. I have been experiencing dizziness currently and it has been two weeks since the symptoms started. I still have a cough. I tested Negative for COVID-19 at home. A lot of my family members had been sick with the same symptoms, and they all tested Negative. I have no sense of taste or smell and it started about a week into the illness.
4" x 2 1/2" area of redness, pain, swelling and heat (L) deltoid. Pt could hardly lift arm. Symptoms took one week to resolve.
Shingles (zoster).  Prescribed antiviral valacyclovir, but was advised that any impact of development of immunity from COVID-19 vaccine is unknown.
Several minutes after shot patient had itching at the injection site. This resolved in about 10 minutes.
retinal eye detachment; zoster-related eye conditions; other zoster-related conditions; zoster-related eye conditions / other zoster-related conditions; Information has been received from a lawyer, regarding a case in litigation, and refers to a patient (pt) of unknown age and gender. No information about the pt's medical history, concurrent conditions or concomitant medications was provided. On or about 13-AUG-2015, the pt was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot # and expiration date were not provided) as prescribed and/or administered by a healthcare provider at a pharmacy for the long-term prevention of shingles and zoster-related conditions. On unknown dates, subsequent to the pt's zoster vaccine live (ZOSTAVAX) inoculation, the pt was treated by various healthcare providers, including but not limited to healthcare provider at an eye hospital, as well as other healthcare providers, for zoster-related eye conditions, retinal eye detachment, and other zoster-related conditions. As a direct and proximate result of the pt's use of zoster vaccine live (ZOSTAVAX), the pt had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. The outcome of the events was considered to be not recovered/not resolved. The reporter considered the events of zoster-related eye conditions, retinal eye detachment, and other zoster-related conditions to be related to zoster vaccine live (ZOSTAVAX).  Upon internal review, the event of retinal detachment was determined to be medically significant.
This spontaneous report as received from a certified medical assistant (reported also as: healthcare worker) refers to an unspecified number of patients of unknown age and gender. Information regarding patients drug reactions or allergies and medical history was not reported. On an unknown date, unspecified number of patients received improperly stored GARDASIL (dose, route of administration, anatomical location, lot#, expiration date were not reported). Concomitant therapies were not reported. No adverse effects were reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
Fever 102.8 degrees- sustained over 72 hours Chills- 48 hours Body Ache- 48 hours Pain and swelling at injection site
Site: Pain at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Headache-Medium, Systemic: Shakiness-Medium, Systemic: Vomiting-Medium
This spontaneous report was received from a physician via a company representative and refers to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, medical history and concomitant therapies was reported. On unknown dates, the patient received first and second dose of GARDASIL 9 (dose, route of administration, lot# and expiration date were not provided). On an unknown date, the patient received an interchanged dose of GARDASIL (dose, route of administration, lot# and expiration date were not provided) instead of GARDASIL 9 as a third dose of the human papilloma virus (HPV) vaccination schedule. There was no symptoms reported. There was no product quality complaints (PQC) involved. Additional information has been requested.
DEVELOPMENT OF BULLOUS PEMPHIGOID APPROXIMATELY 3 WEEKS AFTER RECEIVING HIGH DOSE FLUZONE.
1. Fever the next morning, Tylenol relieved the symptom. Fever came back later that evening, took Tylenol again, fever did not return.  2. Persistent redness/soreness: a large area remains red and sore 4 days after vaccine was administered. Red area is about 3.5 inches in diameter.
MD office called to let us know of ADE and that Pt wanted to go to hospital. They stated she had hives all over, swelling at injection site, pain that was going away, and discoloration of skin like a bruise.
Immediately after receiving Covid vaccine, patient felt dizzy and developed headache. She was brought to stretcher where she laid down and then felt numbness and tingling around mouth. Her throat also felt dry. She was given water and rested for several minutes. Symptoms did not worsen and she started to feel better. After 30 minutes patient states she feels much better. Throughout entire episode, patient was conversant and did not experience any severe symptoms.
Pt devel generalized hives on evening of 18JUN91; ?fever; Seen by MD for symptomatic treatment 19JUN91; Was not acutely ill;
it felt like really bad acid reflux; weakness; burning sensation; dizziness; vaccination site swelling up; This spontaneous case was reported by a consumer and describes the occurrence of GASTROOESOPHAGEAL REFLUX DISEASE (it felt like really bad acid reflux), ASTHENIA (weakness), BURNING SENSATION (burning sensation), DIZZINESS (dizziness) and VACCINATION SITE SWELLING (vaccination site swelling up) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     Concomitant products included LOVASTATIN, FLUOXETINE and TRAMADOL for an unknown indication.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced VACCINATION SITE SWELLING (vaccination site swelling up). On 07-Apr-2021, the patient experienced GASTROOESOPHAGEAL REFLUX DISEASE (it felt like really bad acid reflux), ASTHENIA (weakness), BURNING SENSATION (burning sensation) and DIZZINESS (dizziness). At the time of the report, GASTROOESOPHAGEAL REFLUX DISEASE (it felt like really bad acid reflux), ASTHENIA (weakness), BURNING SENSATION (burning sensation), DIZZINESS (dizziness) and VACCINATION SITE SWELLING (vaccination site swelling up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        .
Headache; muscle soreness; 101.4 degree fever; chills; nausea; This is a spontaneous report from a contactable consumer (patient). A 32-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number: EN6199, Expiration Date: not reported), via an unspecified route of administration, administered in right arm on 04Mar2021 at 12:15 (at the age of 32 years old) as dose number unknown, single for COVID-19 immunisation in a hospital. Medical history included COVID-19 from an unknown date and unknown if ongoing. Concomitant medications included omeprazole; cetirizine hydrochloride (ZYRTEC) and fish oil - all taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 05Mar2021, the patient experienced headache, muscle soreness, 101.4 degree fever, chills and nausea. No treatment was received for the adverse events. Since vaccination, the patient has not been tested for COVID-19. Outcome of all events was recovered on an unspecified date.  No follow-up attempts are possible. No further information is expected.
Awakened @ 3AM w/inconsolable screaming, lasting about 15 min, w/shaking of the hands & some stiffening; That subsided p/a few minutes, then occurred again; then went to sleep;
I had muscle spasms, cramping and aching cause lots of anxiety lasting a week intermittent not consistent. I went to ER for muscle spasm and heart burn prescribed medication and follow up with my doctor.
Normal systemic reaction, plus frequent urination (3/4 times/hour), with groin pain when urinating. Drank fluids, took Motrin, became better after 60 hours.
Got a cortisone injection for the arthritis on his knees between doses; This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Got a cortisone injection for the arthritis on his knees between doses) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Got a cortisone injection for the arthritis on his knees between doses). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (Got a cortisone injection for the arthritis on his knees between doses) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not provided Treatment information was not provided
Significant worsening of tinnitus. Before this flu shot, I had low-level tinnitus noise mostly in the evenings. After this flu shot, the tinnitus increased to moderate or more in noise level, and persists throughout the day. It has been one week since the flu shot now, and the tinnitus has not decreased at all.
The patient was worried if he was protected; The patient had received Jynneos just under the skin; Case reference number US-BN-2022-002148 is a spontaneous case report initially received on 26-Aug-2022 from a consumer via Bavarian Nordic and concerns a male patient of unknown age.  The patient's medical history and concomitant medication details were not provided.  On 26-Aug-2022, the patient was vaccinated with the first dose of Jynneos vaccine (smallpox and monkeypox vaccine, live, nonreplicating; batch number: unknown) at an unknown dose, administered 'just under the skin', as reported (explicitly coded as 'inappropriate route of vaccination'), for unknown indication. On the same day, the patient was worried if that was enough to be protected.  It was also reported that the patient experienced no side effects.  At the time of this report, the outcome of the event 'worry' was unknown.   The reporter did not provide seriousness and causality assessment for the reported event.  Additional information received from Bavarian Nordic on 29-Aug-2022 included the local BN case ID.; Reporter's Comments: A male patient of unknown age was worried if the the vaccination would be enough to be protected, on the same day when he was vaccinated with the first dose of Jynneos, at an unknown dose, administered just under the skin which is considered as inappropriate route of vaccination. Anxiety is unlisted and unexpected according to RA v1 and RA for Jynneos while incorrect route of product administration is considered listed per company convention. Reportedly, the patient experienced no side effects while medical history and concomitant medication details were not provided. Anxiety is assessed as not related to suspect product but to suspect product but to patient's specific thoughts and behavior regarding the vaccine protective effect. Incorrect route of product administration is assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: A male patient of unknown age was worried if the the vaccination would be enough to be protected, on the same day when he was vaccinated with the first dose of Jynneos, at an unknown dose, administered just under the skin which is considered as inappropriate route of vaccination. Anxiety is unlisted and unexpected according to RA v1 and RA for Jynneos while incorrect route of product administration is considered listed per company convention. Reportedly, the patient experienced no side effects while medical history and concomitant medication details were not provided. Anxiety is assessed as not related to suspect product but to suspect product but to patient's specific thoughts and behavior regarding the vaccine protective effect. Incorrect route of product administration is assessed as not related to suspect product but to human factor. The case is non-serious.
Hives has gotten progressively worse. Seem allergists a couple of times. Has tried taking a combination of medications such as Clarinex, Zantac, Doxepin and Benadryl with no alleviating effects.
Full body hives (urticaria) started appearing around 9am on 8/6/2021. Controlled with diphenhydramine 25-50mg every 5 hours for the first ~24 hours. The next morning my upper lip started swelling too so I visited an ER and received IV famotidine (20mg) and d-Chlorpheniramine maleate (5mg) followed by a daily allergy pill which controlled the symptoms. It seems to have resolved by 8/11/2021
cough, shortness of breath, diarrhea, wheezing. Did have one night where he was unable to sleep flat due to shortness of breath but did sleep in bed flat last night. Symptoms have been persistent since onset, but do feel like they are improving slowly.. starting 10/4/21
Patient was found on the floor of pharmacy lobby. He was responsive and stated that he felt faint and that he had a fear of needles. He said that he sat down and put his legs in the  air because that often helped him in the past. He appeared ashen. He denied falling and said he did not hit his head. He denied hurting himself as he sat down. I asked if I could check his blood pressure. It was 122/73 and pulse was 88, all within normal ranges. I requested he sit for 30 minutes for further monitoring. He denied offer for EMT or other help. I recommended that he not drive or operate any heavy machinery.  He sat for the duration of the time and left with a caregiver.
3/16/16 Soreness, swollen; 3/17, 3/18, 19, 20, 21, 22, 23, 24, 25, 26, and 27, sick; felt very strange internally; weakness; headache; no appetite; very sleepy; hot and cold internally; felt back to half normal 3/28/16. Will not take another.
Patient presented to the ER on 2/3/2021 with a seizure 2 weeks after his Pfizer vaccination, and was found to have striking inflammatory lesions on MRI that we presume are related to inflammatory CAA.  We placed him on steroids and his edema has resolved. He feels back to his baseline. We're uncertain to what degree the induction of an inflammatory response by the vaccine might have precipitated this event (of course it did not precipitate his CAA) but to be on the safe side, we stated that he should not get his second COVID vaccination.
This spontaneous report as received from a registered nurse refers to a unspecified number of patients of unknown age and gender. On an unknown date unspecified number of patient were vaccinated with doses if improperly stored (8-9 F for 9 days) PROQUAD (lot number, expiration date, strength, dose, route and indications were not reported). No adverse effects were reported. No product quality complaint (PQC) was reported. This is one of several reports from the same reporter. Additional information has been requested.
pt had 3 episodes of possible sz-high fever-mom called EMS;pt hosp & sent home on heart/apnea monitor;had nl EEG & MD feels it will be best for pt to rect DT in the future;
A pharmacist reported that a 24 year old pt received Flu Shield on 10/9;99 and within hours developed an injection site reaction characterized by pain, warmth, swelling and a 2 inch area of redness. The pt recovered within 3 - 4 days. this is 1 of 2 pt's from this facility who experienced an injection site reaction following receipt of Flu Shield lot number 4998231. Additional information received on 11/1/99 indicated the gender of the pt and the county of vaccine administration.
When I got the vaccine, I felt pain and for rest of day I felt pain constant pain. When I woke up pain was gone and then right after noon I thought I was having a heart attack I had severe chest pain, numb left arm. Went to Hospital ER, they ran a bunch of test, tested me for Covid was negative, did a CT scan and found blood clots in Lungs. They gave me eliquis and oxygen, I was on oxygen for 6 months and observed me for 2 days. I was on an IV i'm not sure what they put in the IV.
Abscessed tooth; This spontaneous case was reported by a consumer and describes the occurrence of TOOTH ABSCESS (Abscessed tooth) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TOOTH ABSCESS (Abscessed tooth). At the time of the report, TOOTH ABSCESS (Abscessed tooth) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant and treatment medications were provided.
Allegry to chemical compound; This is a spontaneous report received from a non-contactable reporter(s) (Pharmacist) from medical information team.  A 73 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "blood pressure" (unspecified if ongoing); "cholesterol" (unspecified if ongoing); "stroke" (unspecified if ongoing); "she had shortness of breath" (unspecified if ongoing), notes: they had to give her something for breathing. Concomitant medication(s) included: ASPIRIN (E.C.) taken for blood pressure measurement, blood cholesterol. Past drug history included: Streptomycin, reaction(s): "Allergic reaction", notes: 40 years ago. The following information was reported: ALLERGY TO CHEMICALS (non-serious), outcome "unknown", described as "Allegry to chemical compound".  Additional information: Her mother is scheduled to receive the Pfizer covid 19 vaccine in 2 days. She looked up the chemical compound and can't tell if is in the vaccine, it could be maybe related to penicillin. Patient had no problem with amoxicillin.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Psychosis; This is a spontaneous report received from a contactable consumer or other non hcp (parent). A 13-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 19May2021 as 1st dose, single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On 22May2021 after receiving of the vaccine patient experienced an episode of psycho-sis, however patient also on an acne medication that could also cause psychosis, so not sure which it could have been from. The outcome of the events was unknown.  Information on the batch/lot number has been requested.
Swollen and irritated arm following injection. Follow up appointment with physician confirmed a skin infection. Patient took a week of antibiotics and is doing fine now.
pt exp redness & edema (2inch by 3inch rectangular) @ edges occuring 2inch below site of vax;intense, sharp demarcated area;